Author: Groeneveld, Geert H; van der Reyden, Tanny J; Joosten, Simone A; Bootsma, Hester J; Cobbaert, Christa M; de Vries, Jutte J C; Kuijper, Ed J; van Dissel, Jaap T
Title: Non-lytic antibiotic treatment in community-acquired pneumococcal pneumonia does not attenuate inflammation: the PRISTINE trial Document date: 2019_5_18
ID: 19ueli6e_41
Snippet: Time to clinical stability and time to defervescence in patients with pneumococcal pneumonia did not differ significantly between treatment groups (Figure 1a and b) . None of the patients with pneumococcal pneumonia died in the hospital or within 30 days, while 90 day overall mortality was 6%. The median length of hospital stay was 4 days and there were no significant differences in ICU admissions, adverse events, and recovery at 30 and 90 days b.....
Document: Time to clinical stability and time to defervescence in patients with pneumococcal pneumonia did not differ significantly between treatment groups (Figure 1a and b) . None of the patients with pneumococcal pneumonia died in the hospital or within 30 days, while 90 day overall mortality was 6%. The median length of hospital stay was 4 days and there were no significant differences in ICU admissions, adverse events, and recovery at 30 and 90 days between the pneumococcal group and the complete cohort. Clinical outcome parameters are described in Tables 2 and 3 .
Search related documents:
Co phrase search for related documents- adverse event and clinical stability: 1, 2
- adverse event and hospital die: 1
- adverse event and hospital stay: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- adverse event and ICU admission: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- adverse event and median length: 1
- adverse event and outcome parameter: 1
- adverse event and overall mortality: 1, 2, 3, 4, 5, 6, 7, 8
- adverse event and significant difference: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- adverse event and significantly differ: 1, 2, 3, 4
- adverse event and treatment group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- clinical outcome parameter and outcome parameter: 1, 2, 3, 4
- clinical outcome parameter and treatment group: 1
- clinical stability and complete cohort: 1
- clinical stability and hospital stay: 1, 2, 3, 4, 5, 6, 7, 8, 9
- clinical stability and ICU admission: 1, 2, 3
- clinical stability and overall mortality: 1, 2
- clinical stability and pneumococcal pneumonia: 1
- clinical stability and significant difference: 1, 2, 3, 4, 5, 6, 7
- clinical stability and time clinical stability: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
Co phrase search for related documents, hyperlinks ordered by date